Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
President and CEO, Director
-
Stock Symbol
-
ENTA on Nasdaq
Jay R. Luly - trading volume in the past year for Enanta Pharmaceuticals Inc
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
802K |
$6.46M |
$8.06 |
Dec 6, 2024 |
Direct |
|
|
| Stock Option (right to buy) |
250K |
|
|
Nov 27, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.